The Cost of Oncology Medicines

1. Bulgarian National Cancer Registry, the incidence of cancer, 2013, http://www.sbaloncology.bg/bg/patients/cancer-info/statistics-pt.htmlSearch in Google Scholar

2. National Health Strategy 2008-2013, Council of Ministers, http://www.sbaloncology.bg/bg/patients/cancer-info/statistics-pt.htmlSearch in Google Scholar

3. National Programme for primary prevention of cervical cancer in the Republic of Bulgaria, the 2012-2016, http://www.mh.government.bg/bg/politiki/programi/aktualni-programi/Search in Google Scholar

4. National strategy for prophylactic cancer screening, http://www.mh.government.bg/bg/novini/aktualno/ministerstvotona-zdraveopazvaneto-osiguriava-100-/Search in Google Scholar

5. Declaration of the National Assembly of the Republic of Bulgaria to restrict and control of oncological diseases in Bulgaria, www.parliament.bg/.../164Declaration%20NC%20za%20onkologichni%...Search in Google Scholar

6. National Programme for Prevention and Control of Cancer in Bulgaria 2009-2018. http://www.parliament.bg/bg/plenaryst/ns/7/ID/660Search in Google Scholar

7. Plan strategy, prevention and control of cancer in the Republic of Bulgaria from 2009 to 2018, the EU and the priorities of Bulgaria, www.ced.bg/uploads/project/EU%202020.docSearch in Google Scholar

8. Ordinance № 40 of 24.11.2004 laying down the basic package of health services guaranteed by the NHIF budget, www.nsoplb.com/uploads/docs/nar_40_112014.rtfSearch in Google Scholar

9. Report for the ongoing implementation of the Law on Budget of NHIF 30.06.2015, www.parliament.bg/.../20151210113120Otchet%20NZOK%20%2030.0...Search in Google Scholar

10. NSI, Health, 2014,http://www.nsi.bg/sites/default/files/files/publications/Zdrave2014.pdf)Search in Google Scholar

11. WHO, Access to new medicines in Europe: technical review of policy initiatives and opportunities for collaboration and researchhttp://apps.who.int/medicinedocs/documents/s21793en/s21793en.pdfSearch in Google Scholar

12. Craig K. Deligdish. Cancer: Exploding Treatment and Diagnostic Pipeline, and Ever-Increasing Costs, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046472,Search in Google Scholar

13. Chris Elkins, How Much Cancer Costs,http://www.drugwatch.com/2015/10/07/cost-of-cancer/Search in Google Scholar

14. Atun R, Analysis of National Cancer Control Programmes in Europe https://spiral.imperial.ac.uk/bitstream/10044/1/4204/1/Cancer%20Control%20vf2.pdfSearch in Google Scholar

15. Mustaqeem Siddiqui, S. Vincent Rajkumar, The High Cost of Cancer Drugs and What We Can Do About It, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538397/Search in Google Scholar

16. McKee A.E., Farrell A.T., Pazdur R., Woodcock J. The role of the U.S. Food and Drug Administration review process: clinical trial endpoints in oncology. Oncologist. 2010;15 (suppl 1):13-18.10.1634/theoncologist.2010-S1-1320237212Search in Google Scholar

17. Spiegel P, Khalifa A, Mateen FJ. Cancer in refugees in Jordan and Syria between 2009 and 2012: Challenges and the way forward in humanitarian emergencies. Lancet Oncol 15:e290-e297, 2014.Search in Google Scholar

18. Scholz F, Schulte H-W, Weißenfeldt F. IMS Health, Parallel trade: Which factors determine the flow of goods in Europe? www.imshealth.de, 2015.Search in Google Scholar